AI assistant
Tessenderlo Group nv — Earnings Release 2016
Aug 24, 2016
4010_ir_2016-08-24_c1682285-4884-4dda-8217-f3d14715cd97.pdf
Earnings Release
Open in viewerOpens in your device viewer
Brussels, August 24, 2016 8:00 am CET Press release
Regulated information1
Tessenderlo Group 2Q16 and HY16 results
Key Events
- In the first half of 2016, Tessenderlo Kerley, Inc. (TKI) announced the startup of its newly installed Sodium Hydrosulfide (NaHS) plant at the Billings, MT facility (facility within our jointventure Jupiter Sulphur LLC). The Billings NaHS plant is strategically located to a reliable sulfur raw material supply and positioned logistically to serve the Western North American market. With this startup, TKI is building on its long history by further expanding its capabilities and offering to the NaHS market.
- In June 2016, the Crop Vitality division of TKI has acquired a research, development and innovation farm in Dinuba, California. The facility will further strengthen Crop Vitality's commitment to developing innovative crop nutrients that help growers meet the needs of modern crop production in a reliable and sustainable manner.
- Construction works of the new Thio-Sul® plants in East Dubuque (US) and Rouen (France) and the new electrolysis plant in Loos (France) are on schedule. Completion date for the construction of the three plants is expected to be in the second half of 2017.
Significant REBITDA increase in 2Q16 thanks to the performance of the operating segments Bio-valorization and Industrial Solutions
| 2Q16 | 2Q15 | % Change |
Million EUR | HY16 | HY15 | % Change |
|---|---|---|---|---|---|---|
| 444.1 | 444.3 | 0.0% | Revenue Group | 855.1 | 850.1 | 0.6% |
| -9.1 | -2.6 | - Other revenue included in revenue Group2 |
-18.2 | -3.9 | ||
| 435.0 | 441.7 | -1.5% | Revenue | 836.8 | 846.2 | -1.1% |
| 72.6 | 56.6 | 28.1% | REBITDA Group | 120.4 | 102.8 | 17.1% |
| -0.3 | 0.8 | - Other REBITDA included in REBITDA Group² |
-0.2 | 1.7 | ||
| 72.3 | 57.4 | 25.9% | REBITDA | 120.2 | 104.5 | 15.1% |
| REBIT Group | 82.9 | 66.6 | 24.5% | |||
| - Other REBIT included in REBIT Group² |
-0.1 | 1.8 | ||||
| REBIT | 82.8 | 68.4 | 21.2% | |||
| Profit (+) / loss (-) for the period |
40.3 | 40.4 | -0.3% | |||
| Total comprehensive income for the period |
29.1 | 39.8 | -26.8% | |||
| Capital expenditure | 47.3 | 20.6 | 129.7% | |||
| Cash flow from operating activities minus capital expenditure |
25.6 | 95.6 | -73.2% | |||
| Net debt | 124.9 | 65.3 | ||||
| Notional net debt | 124.9 | 87.5 |
Remark:
- All quarterly information included in the press release is unaudited.
1 The enclosed information constitutes regulated information as defined in the Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market.
2 The line "Other" refers to engineering and construction activities of the subsidiary Tessenderlo Kerley Services Inc., for the joint venture Jupiter Sulphur LLC, which were reported previously within the Agro segment. The line "Other" has been created for 2016 reporting as a material contract is under execution. The 2Q15 and HY15 comparable figures for the similar activity are also provided.
Revenue
2Q16 revenue decreased by -1.5% compared to the same period last year (or increased by 0.4% when excluding the foreign exchange effect). Revenue excluding foreign exchange effect increased within Industrial Solutions (+9.5%), Bio-valorization revenue was in line with prior year (+0.4%), while Agro revenue decreased (-5.0%).
The HY16 revenue decreased by -1.1% or increased by 0.2% when excluding the foreign exchange effect. Industrial Solutions revenue increased by 9.0% when excluding the foreign exchange effect, mainly within Plastic Pipe Systems and Performance Chemicals3 . The revenue within Bio-valorization increased by 1.3% when excluding the foreign exchange effect, where a slight decrease in Akiolis could be offset by a Gelatin increase. Agro revenue decreased by -6.0% when excluding the foreign exchange effect, mainly being negatively impacted by the decrease of SOP Plant Nutrition.
REBITDA
The 2Q16 REBITDA increased by 25.9% or by 27.2% when excluding the foreign exchange effect, and includes a reversal of an inventory write-off of 1.4 million EUR (-3.7 million EUR in 2Q15).
Key contributor to the 2Q16 REBITDA increase is the operating segment Bio-valorization, the REBITDA of Industrial Solutions increased slightly, while the Agro REBITDA remained stable.
The HY16 REBITDA increased by 15.1% or by 15.6% when excluding the foreign exchange effect. The HY16 REBITDA includes a write-off for inventory obsolescence for -2.8 million EUR (-12.1 million EUR in HY15).
The HY REBITDA increase can be explained by the better performance of Bio-valorization and Industrial Solutions, while the Agro REBITDA decreased, the latter being impacted by the decrease within SOP Plant Nutrition.
Net financial debt
At the end of June 2016, group net financial debt amounted to 124.9 million EUR, resulting in a leverage of 0.6x. Net financial debt as per year-end 2015 amounted to 145.3 million EUR. The cash flow from operating activities amounts to 72.9 million EUR (116.2 million EUR in HY15), partially offset by the capital expenditure of 47.3 million EUR (20.6 million EUR in HY15). The increase of the capital expenditure in HY16 compared to HY15 can be explained by the further execution of previously announced growth projects.
Profit (+) / loss (-) for the period
The HY16 profit amounts to 40.3 million EUR compared to 40.4 million EUR in the same period last year. The increase of the operational results and the decrease of the non-recurring and non-operating items were offset by higher net finance costs (negatively impacted by unrealized exchange losses on non-hedged intercompany loans) and increased income tax expenses.
Outlook
Considering the lower SOP Plant Nutrition results in HY16 and its expectations for the full year, the Group anticipates that the 2016 REBITDA, compared to the 2015 REBITDA (180.4 million EUR), may grow around 15%.
However the group wants to emphasize that it currently operates in a volatile economic and financial environment.
3 As from 2016, the businesses Water Treatment and Sulfur Derivatives are combined within Performance Chemicals.
Operating segments performance review
| GROUP KEY FIGURES - YEAR TO DATE | |||
|---|---|---|---|
| Million EUR | HY16 | HY15 | % change |
| Revenue | 855.1 | 850.1 | 0.6% |
| Agro | 346.6 | 368.8 | -6.0% |
| Bio-valorization | 244.0 | 249.0 | -2.0% |
| Industrial Solutions | 246.3 | 228.3 | 7.9% |
| Other | 18.2 | 3.9 | 364.6% |
| REBITDA | 120.4 | 102.8 | 17.1% |
| Agro | 78.9 | 89.1 | -11.5% |
| Bio-valorization | 13.4 | -7.5 | nm |
| Industrial Solutions | 27.9 | 22.9 | 22.0% |
| Other | 0.2 | -1.7 | nm |
| REBIT | 82.9 | 66.6 | 24.5% |
| Agro | 66.7 | 78.8 | -15.3% |
| Bio-valorization | -2.4 | -21.7 | 88.8% |
| Industrial Solutions | 18.6 | 11.3 | 64.8% |
| Other | 0.1 | -1.8 | nm |
| Non-recurring and non-operating income/(expense) items |
-3.8 | -20.0 | 80.9% |
| EBIT | 79.1 | 46.6 | 69.7% |
| AGRO | |||
|---|---|---|---|
| Million EUR | HY16 | HY15 | % change |
| Revenue | 346.6 | 368.8 | -6.0% |
| REBITDA | 78.9 | 89.1 | -11.5% |
| REBITDA margin | 22.8% | 24.2% | |
| REBIT | 66.7 | 78.8 | -15.3% |
| REBIT margin | 19.2% | 21.4% |
HY16 revenue decreased by -6.0% (equal impact when excluding the foreign exchange effect), mainly a consequence of the decrease of revenue within SOP Plant Nutrition.
The HY16 REBITDA decreased by -11.5% compared to prior year (equal impact when excluding the foreign exchange effect). The decrease of the SOP Plant nutrition REBITDA could not be compensated by the other Agro businesses.
| BIO-VALORIZATION | ||||
|---|---|---|---|---|
| Million EUR | HY16 | HY15 | % change | |
| Revenue | 244.0 | 249.0 | -2.0% | |
| REBITDA | 13.4 | -7.5 | nm | |
| REBITDA margin | 5.5% | -3.0% | ||
| REBIT | -2.4 | -21.7 | 88.8% | |
| REBIT margin | -1.0% | -8.7% |
Revenue decreased by -2.0% in HY16 or increased by +1.3% when excluding the foreign exchange effect.
The REBITDA increased from -7.5 million EUR as per HY15 to 13.4 million EUR as per HY16. The HY15 result was negatively impacted by an inventory write-off, which was a consequence of changed accounting estimates concerning inventory obsolescence. Better operational performance and the impact of cost reduction measures further improved the HY16 REBITDA.
| INDUSTRIAL SOLUTIONS | ||||
|---|---|---|---|---|
| Million EUR | HY16 | HY15 | % change | |
| Revenue | 246.3 | 228.3 | 7.9% | |
| REBITDA | 27.9 | 22.9 | 22.0% | |
| REBITDA margin | 11.3% | 10.0% | ||
| REBIT | 18.6 | 11.3 | 64.8% | |
| REBIT margin | 7.5% | 4.9% |
The HY16 revenue of the segment Industrial Solutions increased by 7.9% (or 9.0% when excluding the foreign exchange rate effect), being positively impacted by the businesses Plastic Pipe Systems and Performance Chemicals.
The HY16 REBITDA increased by 22.0% or by 22.6% when excluding the foreign exchange rate effect. This evolution is mainly supported by the improved performance of Plastic Pipe Systems.
Condensed consolidated financial information at June 30, 2016
The group also published the 2016 interim report, which can be found on www.tessenderlo.com. The half year information has been subject to a review by external auditors. Reference is made to their independent auditor's review in the interim report.
| CONSOLIDATED INCOME STATEMENT | ||
|---|---|---|
| Million EUR | HY16 | HY15 |
| Revenue | 855.1 | 850.1 |
| Cost of sales | -629.3 | -640.0 |
| Gross profit | 225.8 | 210.1 |
| Distribution expenses | -49.2 | -49.6 |
| Sales and marketing expenses | -29.5 | -26.6 |
| Administrative expenses | -55.9 | -57.9 |
| Other operating income and expenses | -8.3 | -9.4 |
| Profit (+) / loss (-) from operations before non-recurring and non operating items (REBIT) |
82.9 | 66.6 |
| Non-recurring and non-operating income/(expense) items | -3.8 | -20.0 |
| Profit (+) / loss (-) from operations (EBIT) | 79.1 | 46.6 |
| Finance (costs) / income - net | -19.3 | 6.0 |
| Share of result of equity accounted investees, net of income tax | 1.8 | 2.3 |
| Profit (+) / loss (-) before tax | 61.6 | 54.9 |
| Income tax expense | -21.4 | -14.5 |
| Profit (+) / loss (-) for the period | 40.3 | 40.4 |
| Attributable to: | ||
| - Equity holders of the company | 40.7 | 41.5 |
| - Non-controlling interest | -0.4 | -1.1 |
| Basic earnings per share (EUR) | 0.95 | 0.98 |
| Diluted earnings per share (EUR) | 0.95 | 0.98 |
| CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | ||
|---|---|---|
| Million EUR | HY16 | HY15 |
| Profit (+) / loss (-) for the period | 40.3 | 40.4 |
| Translation differences | 3.5 | -10.4 |
| Net change in fair value of derivative financial instruments, before tax | -1.2 | 0.1 |
| Other movements | 0.1 | -0.0 |
| Income tax on other comprehensive income | 0.4 | -0.0 |
| Other comprehensive income to be reclassified to profit or loss in subsequent periods |
2.9 | -10.4 |
| Remeasurements of the net defined benefit liability, before tax | -14.0 | 10.9 |
| Income tax on other comprehensive income | 0.0 | -1.1 |
| Other comprehensive income not being classified to profit or loss in subsequent periods |
-14.0 | 9.8 |
| Other comprehensive income for the period, net of income tax | -11.1 | -0.6 |
| Total comprehensive income for the period | 29.1 | 39.8 |
| Attributable to: | ||
| - Equity holders of the company | 29.5 | 40.7 |
| - Non-controlling interest | -0.4 | -0.9 |
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
| Million EUR | 30.06.2016 | 31.12.2015 |
|---|---|---|
| ASSETS | ||
| Total non-current assets | 633.8 | 628.9 |
| Property, plant and equipment | 482.5 | 462.3 |
| Goodwill | 34.9 | 35.3 |
| Other intangible assets | 49.5 | 59.3 |
| Investments accounted for using the equity method | 24.4 | 25.1 |
| Other investments | 1.9 | 2.0 |
| Deferred tax assets | 30.7 | 30.0 |
| Trade and other receivables | 10.0 | 14.9 |
| Total current assets | 698.5 | 673.3 |
| Inventories | 272.0 | 288.9 |
| Trade and other receivables | 285.9 | 253.2 |
| Derivative financial instruments | 0.1 | 1.0 |
| Cash and cash equivalents | 140.5 | 130.2 |
| Non-current assets classified as held for sale | 0.1 | 1.4 |
| Total assets | 1,332.5 | 1,303.6 |
| EQUITY AND LIABILITIES | ||
| Total equity | 546.3 | 518.2 |
| Equity attributable to equity holders of the company | 544.8 | 516.8 |
| Issued capital | 215.0 | 215.0 |
| Share premium | 232.9 | 232.9 |
| Reserves and retained earnings | 97.0 | 69.0 |
| Non-controlling interest | 1.5 | 1.5 |
| Total liabilities | 786.2 | 785.4 |
| Total non-current liabilities | 471.2 | 468.2 |
| Loans and borrowings | 227.4 | 226.7 |
| Employee benefits | 59.8 | 48.3 |
| Provisions | 130.1 | 135.0 |
| Trade and other payables | 3.9 | 4.3 |
| Derivative financial instruments | 11.8 | 11.1 |
| Deferred tax liabilities | 38.3 | 42.7 |
| Total current liabilities | 315.0 | 317.2 |
| Bank overdrafts | 0.1 | 0.5 |
| Loans and borrowings | 37.9 | 48.3 |
| Trade and other payables | 244.0 | 243.4 |
| Derivative financial instruments | 6.4 | 6.3 |
| Current tax liabilities | 9.7 | 0.7 |
| Employee benefits | 1.0 | 1.7 |
| Provisions | 15.8 | 16.3 |
| Total equity and liabilities | 1,332.5 | 1,303.6 |
| CONSOLIDATED STATEMENT OF CASH FLOWS | ||
|---|---|---|
| Million EUR | 30.06.2016 | 30.06.2015 |
| OPERATING ACTIVITIES | ||
| Profit (+) / loss (-) for the period | 40.3 | 40.4 |
| Depreciation, amortization and impairment losses on tangible assets, goodwill and other intangible assets |
39.5 | 39.8 |
| Changes in provisions | -5.4 | 4.7 |
| Finance costs / (income) - net | 19.3 | -6.0 |
| Loss / (profit) on sale of non-current assets | 0.2 | -6.3 |
| Share of result of equity accounted investees, net of income tax | -1.8 | -2.3 |
| Income tax expense | 21.4 | 14.5 |
| Other non-cash items | -0.7 | -0.7 |
| Changes in inventories | 9.3 | 30.6 |
| Changes in trade and other receivables | -46.7 | -29.8 |
| Changes in trade and other payables | -0.0 | 10.8 |
| Change in accounting estimates - inventory write off | 2.8 | 21.6 |
| Revaluation electricity forward contract | 1.7 | 0.0 |
| Cash generated from operations | 79.8 | 117.4 |
| Income tax (paid)/received | -7.2 | -1.9 |
| Dividends received | 0.3 | 0.7 |
| Dividends received from other investments | 0.1 | 0.0 |
| Cash flow from operating activities | 72.9 | 116.2 |
| INVESTING ACTIVITIES | ||
| Acquisition of property, plant and equipment | -47.3 | -20.3 |
| Acquisition of other intangible assets | -0.0 | -0.3 |
| Acquisition of businesses, net of cash acquired | -3.3 | -2.1 |
| Proceeds from the sale of property, plant and equipment | 1.3 | 3.1 |
| Proceeds from the sale of subsidiaries, net of cash disposed of | -0.6 | - |
| Proceeds from the sale of other investments | - | 6.7 |
| Cash flow from investing activities | -49.8 | -12.8 |
| FINANCING ACTIVITIES | ||
| Capital increase from non-controlling interests | - | 0.6 |
| Change in non-recourse factoring and securitization | - | -76.0 |
| Proceeds from new borrowings | 2.2 | 7.3 |
| (Reimbursement) of borrowings | -13.3 | -14.8 |
| Cash movement resulting from settlement financial instruments | - | -31.6 |
| Interest paid | -0.2 | -2.9 |
| Interest received | 0.3 | 0.3 |
| Other finance costs paid | -0.9 | -2.2 |
| Decrease of long term receivables | 0.6 | 0.1 |
| Cash flow from financing activities | -11.4 | -119.2 |
| Net increase / (decrease) in cash and cash equivalents | 11.8 | -15.8 |
| Effect of exchange rate differences | -1.1 | 1.0 |
| Cash and cash equivalents less bank overdrafts at the beginning of the period |
129.7 | 156.5 |
| Cash and cash equivalents less bank overdrafts at the end of the period |
140.4 | 141.7 |
Financial calendar
Third quarter 2016 trading update October 25, 2016 Full year results 2016 March 1, 2017
Agenda for August 24, 2016
3pm CET/2pm UK - conference call and webcast for analysts and investors Registration details are available at: http://www.tessenderlo.com
Tessenderlo Group is a worldwide specialty company, focused on food, agriculture, water management and on valorizing bio-residuals. The group employs about 4,700 people and is a leader in most of its markets, with a consolidated revenue of 1.6 billion EUR in 2015. Tessenderlo Chemie NV is listed on Euronext Brussels and is part of Next 150 and BEL Mid indices. Financial News wires: Bloomberg: TESB BB – Reuters: TesBt.BR – Datastream: B:Tes
Media Relations Investor Relations Frederic Dryhoel Kurt Dejonckheere +32 2 639 19 85 +32 2 639 18 41
[email protected] [email protected]
This press release is available in Dutch and English on the corporate website www.tessenderlo.com - under 'News & Media'